Immunovia publ AB
Research Immunovia publ AB (IMMNOV) on Bullrun: market cap SEK 102.38M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIMMNOV
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencySEK
- Market capSEK 102.38M
- Financial periodQ1 2026
- RevenueSEK 374.00K
- Net income-SEK 18.43M
- Free cash flow-SEK 20.89M
- Gross margin61.8%
Valuation Snapshot
latest market cap is SEK 102.38M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 684.00K | -SEK 145.91M | -SEK 83.96M | n/a | -0.4 | SEK 77.46M | SEK 857.00K | SEK 64.77M |
| FY2023 | SEK 1.80M | -SEK 309.44M | -SEK 147.06M | n/a | -7.95 | SEK 76.79M | n/a | SEK 66.99M |
| FY2022 | SEK 1.20M | -SEK 168.09M | -SEK 176.84M | n/a | -7.43 | SEK 106.04M | n/a | SEK 243.80M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 102.38M | n/a | n/a | n/a |
About Immunovia publ AB
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Immunovia publ AB's market cap?
Immunovia publ AB's market capitalization is SEK 102.38M.
What does Immunovia publ AB do?
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.